MedPath

Evaluation of botolinum toxin on preventing of scar

Phase 3
Recruiting
Conditions
scar.
Hypertrophic scar
Registration Number
IRCT20180826040876N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Patients with mammoplasty and abdominoplasty scar, operated during past 10 days

Exclusion Criteria

Allergy to botox
Pregnancy and breastfeeding
History of radiotherapy and chemotherapy
Neuromotor diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Modified Stony Brook Scar Evaluation Scale. Timepoint: 3&6 month after injection. Method of measurement: Including 4 factors: width, height, scar color and incision line. scoring is based on 0-8.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath